Back
Hikma Pharmaceuticals Plc 10K Form
Sell
24
HKMPY
Hikma Pharmaceuticals Plc
Last Price:
$42.73
Seasonality Move:
2.89%
7 Day Trial
ALL ACCESS PASS
$
7
Key Filings
10K form not available
Receive HKMPY News And Ratings
See the #1 stock for the next 7 days that we like better than HKMPY
HKMPY Financial Statistics
Sales & Book Value
| Annual Sales: | $3.1B |
|---|---|
| Cash Flow: | $0 |
| Price / Cash Flow: | 31.36 |
| Annual Sales: | $22.92 |
| Price / Book: | 2.11 |
Profitability
| EPS (TTM): | 3.37930 |
|---|---|
| Net Income (TTM): | $375.1M |
| Gross Margin: | $1.3B |
| Return on Equity: | 15.52% |
| Return on Assets: | 7.17% |
Hikma Pharmaceuticals Plc Earnings Forecast
Key Hikma Pharmaceuticals Plc Financial Ratios
-
The Gross Profit Margin over the past 23 years for HKMPY is 42.44%.
-
The Selling, General & Administrative Expenses for HKMPY have been equal to 21.46% of Gross Profit Margin.
-
The Research & Development expenses have been 4.51% of Revenue.
-
The Interest Expense is 24.31% of Operating Income.
-
The Net Earning history of HKMPY is 11.58% of Total Revenues.
-
Per Share Earnings over the last 23 years have been positive in 14 years.
Hikma Pharmaceuticals Plc Stock Price Chart
Industry, Sector and Symbol
| Stock Exchange: | OTCM |
|---|---|
| Current Symbol: | HKMPY |
| Website: | hikma.com |
Debt
| Debt-to-Equity Ratio: | 0.59 |
|---|---|
| Current Ratio: | 1.24 |
| Quick Ratio: | 0.65 |
Price-to-Earnings
| Trailing P/E Ratio: | 13.3 |
|---|---|
| Forward P/E Ratio: | 0 |
HKMPY Technical Analysis vs Fundamental Analysis
Sell
24
Hikma Pharmaceuticals Plc (HKMPY)
is a Sell
Is Hikma Pharmaceuticals Plc a Buy or a Sell?
-
Hikma Pharmaceuticals Plc stock is rated a SellThe current Hikma Pharmaceuticals Plc [HKMPY] share price is $42.73. The Score for HKMPY is 24, which is 52% below its historic median score of 50, and infers higher risk than normal.